Pimecrolimus cream 1%
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Atopic Eczema
Conditions
Atopic Eczema
Trial Timeline
Oct 1, 2004 → Dec 1, 2004
NCT ID
NCT00484003About Pimecrolimus cream 1%
Pimecrolimus cream 1% is a approved stage product being developed by Novartis for Atopic Eczema. The current trial status is completed. This product is registered under clinical trial identifier NCT00484003. Target conditions include Atopic Eczema.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00367393 | Approved | Completed |
| NCT00150059 | Approved | Completed |
| NCT00484003 | Approved | Completed |
| NCT00226707 | Phase 3 | Completed |
| NCT00232011 | Phase 3 | Completed |
Competing Products
20 competing products in Atopic Eczema